Premium grade bioactive compounds optimized for pharmaceutical formulation, metabolic research, and nutraceutical applications in Qatar and the GCC region.
Doha, the political and economic heart of Qatar, is rapidly positioning itself as a high-tech biopharmaceutical and healthcare hub in the Middle East. Driven by the ambitious Qatar National Vision 2030, the nation is actively diversifying its economy away from hydrocarbon dependency by nurturing advanced manufacturing sectors, with biotechnology and pharmaceutical formulation at the absolute forefront.
The establishment of advanced scientific infrastructure—such as the Qatar Science & Technology Park (QSTP), Hamad Bin Khalifa University's research labs, and world-class logistics facilities in the Qatar Free Zones (Umm Alhoul and Ras Bufontas)—creates an optimal environment for clinical research and the local formulation of high-value natural therapeutics. As Qatar invests heavily in its domestic pharmaceutical security, the demand for high-purity, standardized Natural Active Pharmaceutical Ingredients (APIs) has risen exponentially.
By leveraging global extraction expertise and localizing the supply of raw botanical materials and secondary metabolites, Doha is setting the stage for a resilient pharmaceutical value chain that caters not only to domestic needs but also serves as a strategic export base for the entire GCC, Middle East, and North Africa (MENA) markets.
The global pharmaceutical and clinical wellness sectors are undergoing a structural paradigm shift. There is a marked transition from purely synthetic small molecules to highly purified, naturally derived active molecules. These compounds, termed Natural APIs, offer complex multi-target therapeutic activities, often displaying superior biocompatibility and reduced side-effect profiles compared to synthetic equivalents.
Metabolic syndromes, inflammatory chronic conditions, and age-related neurodegenerative diseases are driving the demand for targeted plant-derived drugs. Compounds like Berberine Hydrochloride, Pterostilbene, and Luteolin are no longer viewed merely as traditional supplements. Modern clinical oncology, metabolic clinics, and cardiology departments are utilizing them as standardized therapeutic agents and adjunct therapies. This shift requires factories that can guarantee absolute chemical purity, consistent enantiomeric profiles, and heavy metal/pesticide-free compliance to satisfy global pharmacopoeias (USP, EP, JP).
Combining abundant botanical resources with state-of-the-art technological pipelines to supply the Middle East with GMP, Halal, and FDA compliant natural APIs.
Established in 2012, Chengdu Chenlv Herb Co., Ltd. is a high-tech enterprise specializing in the research, development, and industrial-scale manufacturing of botanical extracts and high-purity natural pharmaceutical ingredients. Located in Chengdu, China—the gateway to the bio-diverse Sichuan basin and Himalayan herbal corridors—our company integrates research, clinical-grade cultivation, state-of-the-art extraction, and global logistics under one unified ecosystem.
Operating a massive 9,514 m² production facility, Chenlv Herb is engineered to satisfy the rigorous demand cycles of international pharmaceutical conglomerates. China's efficiency advantages in this sector are clear: fully integrated supply chains, lower capital expenditure on specialized hardware, high-throughput extraction technologies (like supercritical CO2 extraction and advanced chromatography), and a deep pool of analytical chemists.
This allows us to offer Doha's pharmaceutical developers and international partners an unbeatable value proposition: cost-efficiency coupled with absolute regulatory compliance, including ISO9001, ISO22000, HALAL, KOSHER, and FDA registrations.
Providing custom botanical synthesis and contract manufacturing services optimized for Middle Eastern regulatory guidelines.
How plant extracts are used locally to solve healthcare, dermatological, and animal welfare challenges.
Formulating clean-label, plant-derived capsules and tablets to address metabolic health, glucose regulation, and overall longevity, ensuring 100% gelatin-free and Halal-compliant raw materials.
Providing active phytomolecules like Berberine Hcl for pharmaceutical companies in Qatar manufacturing anti-diabetic and cardiovascular supportive prescription formulations.
Integrating powerful botanical antioxidants (Tetrahydrocurcumin, Pterostilbene) to formulate skin barrier defense serums customized for Qatar's high UV and desert climate.
Supplying functional feed additives containing natural anti-inflammatory molecules (Andrographolide) for Qatar's elite camel racing, falconry, and equine sports sectors.
Procuring natural pharmaceutical raw materials is a highly regulated process. Global procurement teams from pharmaceutical manufacturers, medical institutions, and consumer brands require rigorous documentation, testing protocols, and verification of chemical consistency. At Chengdu Chenlv Herb, we streamline this complex compliance landscape by offering:
Establish exact purity thresholds, physical state (powder/granules), solubility profiles, and target delivery schedules.
Ensure import compliance with Qatari customs and Ministry of Public Health standards, detailing pricing brackets.
Provide laboratory scale pilot samples with supporting stability study datasets for local evaluation.
Production at our 9,514 m² high-capacity factory, ensuring batch-to-batch consistency and fast delivery timelines.
Complete product range supplied globally under strict quality control, verified by third-party testing laboratories.
Analyzing key advancements shaping natural active compound synthesis and purification.
Using supercritical CO2 to extract highly labile phytochemical compounds without heat-induced degradation, maintaining chemical integrity and delivering maximum bio-potency.
Utilizing deep learning models to predict batch synergy, structural properties, and pharmacodynamic interactions before starting long production runs.
Every shipment includes complete digital crop traceability data, starting from local farm sourcing to final crystallization and shipping.
Get professional answers regarding regulatory compliance, customized extraction options, and GCC supply chains.
Yes. All botanical extracts and active pharmaceutical ingredients supplied to Doha and the wider GCC region comply with major international pharmacopoeias (USP, EP, and BP). We provide complete documentation packets, including DMFs (Drug Master Files), Certificate of Suitability (CEP), full batch chromatograms (HPLC/GC-MS), and heavy metal/microbiology screening reports to facilitate direct approval from the Qatar Ministry of Public Health registration bodies.
Absolutely. Recognizing the religious and quality requirements of the Middle East market, our processing pipelines are audited and certified by recognized Halal and Kosher accreditation boards. We utilize exclusively non-animal, plant-derived solvents and processing aids, and our products are completely free from porcine or alcohol contaminants.
For standard catalog APIs (such as Berberine Hcl or Luteolin), MOQs start as low as 25kg. For custom extraction processes or contract manufacturing formulations involving specific purity targets or unique solvents, the MOQ generally ranges between 100kg and 500kg, depending on the availability of the raw botanical materials and the complexity of the molecular isolation process.
We work with leading international pharmaceutical logistics partners (including DHL, FedEx, and specialized cold-chain ocean cargo services) to manage custom clearances. We maintain standard sea freight routes into Hamad Port and express air freight lanes direct to Hamad International Airport (DOH), complete with temperature-controlled shipping options to prevent heat denaturation during transit in desert regions.
Partner with Chengdu Chenlv Herb to acquire high-purity, standardized plant extracts backed by full regulatory validation and advanced Chinese factory efficiency.
Send Inquiry Now
Chenlv Herb